ArticleBlood2026

CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.

Joseph M Rocco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.